Be Part of
the Movement.
Take On
Big Pharma.
A New Zealand couple spent 20 years building something the giants refused to. Now with FDA listing, 5-star reviews on Amazon, and a 14-product pipeline, they’re inviting you to own a piece of the fight.
David vs Goliath.
This time, David has an Asteroid in his sling
Big pharma has dominated the US self-care market for decades, delivering the same tired formulas with billion-dollar marketing budgets. Two NZ pharmacists decided enough was enough.
- ✕Steroid-based formulas used for decades, raising safety concerns
- ✕Retail shelf dominated, low margins, low loyalty
- ✕Low consideration for customers feelings
- ✕Treatments in isolation, no lifestyle advice
- ✕No NZ connection, no real urgency to disrupt
- ✓Steroid-free formulation, effective and safe for daily use
- ✓The only FDA-listed topical OTC haemorrhoid medicine with 5-way action and ‘rapid acting’ label claim in US market.
- ✓Already live on Amazon.com from January 2026 at USD $29.99
- ✓E-commerce, 14 product pipeline covering analgesics, digestive health, allergy and weight management to follow.
- ✓Built from New Zealand — and you can own a piece of it
One couple’s dream. Two decades of graft.
Tim O’Donoghue is a pharmacist, entrepreneur, and former University of London lecturer who spent years listening to what real people actually needed. Alice Delee brings deep expertise in women’s consumer health. Together they built Neoqura and Asteroid™ from the ground up.
This isn’t a startup on a whiteboard. This is a product that is already selling, already FDA-listed, already earning 5 stars on the world’s largest marketplace. They built it so that New Zealanders could share in what comes next.
Pharmacist-designed.
FDA-listed.
Already winning.
Asteroid™ Ointment is unlike anything else on the US market. 5-way action in one steroid-free formula. Rapid cooling action. Discreet, elegant packaging. Built for a generation that asked for better -and got it!
We’re building a platform of 14 over-the-counter medicines for the US market… all 14 have US FDA listings and are ready to go to market following Asteroid
The window is open.
It won’t stay that way.
This is the moment before the story is widely known. Be part of the founding chapter of a New Zealand company taking the fight to one of the world’s most powerful industries.